Tear glucose-responsive and photo-activated antibacterial hydrogel bandage with bio-heterojunction for the treatment of drug-resistant bacterial corneal infection
Acta Biomaterialia · 2026-03 · 213 · 292-313
DOI: 10.1016/j.actbio.2026.02.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-03. Verfasst von Liangyu Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The University of Hong Kong, Hong Kong 999077, China; Advanced Biomedical Instrumentation Centre, Hong Kong Science Park…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Bacterial, Keratitis, Hydrogels. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Innovation and Technology Commission.
Abstract (Originalsprache)
Bacterial keratitis (BK) contributes to more than half of the cases of corneal infection, which is caused by bacterial infection on cornea. BK can lead to severe vision loss or even blindness if appropriate treatment is not provided in a timely manner. However, the indiscriminate use of antibiotics can lead to antimicrobial resistance and potential cytotoxicity to the surrounding healthy tissue. To provide effective and safe treatment for BK, an antibiotic-free tear glucose responsive and photoactive hydrogel bandage (tgr-PAHB) is established. The tgr-PAHB consists of poly-ε-lysine (pεK) hydrogel encapsulating photoactive graphene oxide/copper ferrite nanoparticles (GO/CFN) bio-heterojunction and immobilized tear-responsive glucose oxidase (GOx). GO/CFN rapidly eliminates bacteria by producing abundant reactive oxygen species (ROS) under near-infrared light (NIR) irradiation and catalyzing the GOx-produced hydrogen peroxide (H2O2). The strong antibacterial property of tgr-PAHB against Staphylococcus aureus and Pseudomonas aeruginosa were investigated in-vitro. Furthermore, the tgr-PAHB can eradicate drug-resistant S. aureus and P. aeruginosa on ex-vivo cornea efficiently. The tgr-PAHB also exhibits efficient treatment efficacy in drug-resistant P. aeruginosa-induced BK in rabbit models. This study suggests tgr-PAHB is promising for rapid and effective treatment for BK caused by antibiotic-resistant bacteria and elucidates a direction for antibiotic-free therapy against infective keratitis. STATEMENT OF SIGNIFICANCE: Bacterial keratitis (BK) is a major cause of irreversible corneal damage and blindness. The widespread use of antibiotics as first-line therapy contributes to increasing antimicrobial resistance, highlighting the need for alternative treatments. Non-antibiotic clinically applied strategies, such as riboflavin-based photodynamic therapy, are limited by risks of photodamage and unintended corneal collagen crosslinking. This article introduces a new reactive oxygen species (ROS)-based material, the Tear Glucose Responsive and Photo-Activated Antibacterial Hydrogel bandage (tgr-PAHB), for treating BK with a safer light source and reduced corneal penetration. The antibacterial efficacy of tgr-PAHB is demonstrated against both Gram-positive and Gram-negative bacteria with drug-resistance in ex-vivo porcine cornea and in-vivo rabbit models, suggesting its potential for broad applications in ocular and other tissue infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The University of Hong Kong, Hong Kong 999077, China; Advanced Biomedical Instrumentation Centre, Hong Kong Science Park, Shatin, New Territories, Hong Kong.
- Department of Ophthalmology, The University of Hong Kong, Hong Kong 999077, China.
- Eye Center, Xiangya Hospital, Central South University, Changsha 410008, China.
- Advanced Biomedical Instrumentation Centre, Hong Kong Science Park, Shatin, New Territories, Hong Kong; Department of Chemistry and Department of Biomedical Engineering, City University of Hong Kong, Hong Kong SAR, Chin…
- Department of Microbiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, China.
- School of Chemical Engineering, Sichuan University, Chengdu 610065, China.
Förderung
- Innovation and Technology Commission
Zitieren
APA
Zhou, L., Zhou, S., Chen, Y., Ren, Y., Gao, X., Shum, H. C., Li, X., Deng, Y., Wang, H., & Chan, Y. K. (2026). Tear glucose-responsive and photo-activated antibacterial hydrogel bandage with bio-heterojunction for the treatment of drug-resistant bacterial corneal infection. Acta Biomaterialia, 213, 292-313. https://doi.org/10.1016/j.actbio.2026.02.042
Vancouver
Zhou L, Zhou S, Chen Y, Ren Y, Gao X, Shum HC, et al. Tear glucose-responsive and photo-activated antibacterial hydrogel bandage with bio-heterojunction for the treatment of drug-resistant bacterial corneal infection. Acta Biomaterialia. 2026;213:292-313. doi:10.1016/j.actbio.2026.02.042
BibTeX
@article{Zhou2026,
author = {Zhou, Liangyu and Zhou, Shuowen and Chen, Ying and Ren, Yujie and Gao, Xiangyu and Shum, Ho Cheung and Li, Xin and Deng, Yi and Wang, Hua and Chan, Yau Kei},
title = {Tear glucose-responsive and photo-activated antibacterial hydrogel bandage with bio-heterojunction for the treatment of drug-resistant bacterial corneal infection},
journal = {Acta Biomaterialia},
year = {2026},
volume = {213},
pages = {292--313},
doi = {10.1016/j.actbio.2026.02.042}
}
EUVIMED